Current options for the therapy of chronic hepatitis B infection
Authors:
- 1 April 2001
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 3 (2) , 137-142
Abstract
Until recently the only available treatment for chronic hepatitis B was interferon-α. Over the past few years a new class of antiviral has become available, the reverse transcriptase inhibitors. Lamivudine is a nucleoside analogue reverse transcriptase inhibitor that was recently approved in many countries for the treatment of hepatitis B. Despite the potent action of lamivudine, the development of new antivirals and new strategies to treat hepatitis B are still the major goal. We review the latest options for therapy of chronic hepatitis B, including combination strategies that could be an approach to improving the response rate of antivirals.Keywords
This publication has 48 references indexed in Scilit:
- Prednisolone Priming Enhances Th1 Response and Efficacy of Subsequent Lamivudine Therapy in Patients With Chronic Hepatitis BHepatology, 2000
- A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis BHepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus‐Infected Patients Following Development of Resistance to or Withdrawal of LamivudineClinical Infectious Diseases, 1999
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Journal of Clinical Investigation, 1998
- Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitroHepatology, 1997
- CONVERSION OF RECURRENT DELTA-POSITIVE HEPATITIS B INFECTION TO SERONEGATIVITY WITH FAMCICLOVIR AFTER LIVER TRANSPLANTATIONTransplantation, 1997
- Impact of Complete Inhibition of Viral Replication on the Cellular Immune Response in Chronic Hepatitis B Virus InfectionHepatology, 1996
- Famciclovir, from the bench to the patient — a comprehensive review of preclinical dataInternational Journal of Antimicrobial Agents, 1996
- Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDSAntiviral Research, 1991